Christine E. Codding

1.9k total citations
9 papers, 1.2k citations indexed

About

Christine E. Codding is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, Christine E. Codding has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 4 papers in Genetics and 3 papers in Hematology. Recurrent topics in Christine E. Codding's work include Rheumatoid Arthritis Research and Therapies (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Christine E. Codding is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Christine E. Codding collaborates with scholars based in United States, Switzerland and Belgium. Christine E. Codding's co-authors include Eva Dokoupilová, Maria Greenwald, Hanno B. Richards, Neal A. Halsey, Flavius Martin, Ariella Kelman, Benjamin Trzaskoma, R. John Looney, Clifton O. Bingham and Sunil Agarwal and has published in prestigious journals such as Annals of the Rheumatic Diseases, American Journal of Kidney Diseases and Arthritis & Rheumatology.

In The Last Decade

Christine E. Codding

9 papers receiving 1.1k citations

Peers

Countries citing papers authored by Christine E. Codding

Since Specialization

Citations

This map shows the geographic impact of Christine E. Codding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. Codding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. Codding more than expected).

Fields of papers citing papers by Christine E. Codding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine E. Codding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. Codding. The network helps show where Christine E. Codding may publish in the future.

Co-authorship network of co-authors of Christine E. Codding

This figure shows the co-authorship network connecting the top 25 collaborators of Christine E. Codding. A scholar is included among the top collaborators of Christine E. Codding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine E. Codding. Christine E. Codding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study 2019 ·Rheumatology and Therapy ·Mark C. Genovese, Maria Greenwald, Sergio Gutiérrez‐Ureña, Mario H. Cardiel, Jeffrey E. Poiley, (unknown), Christine E. Codding, Annie Wang, Weizhong He, (unknown), Raúl Vinueza, Xuegong Wang, Jay Garg, Alan Kivitz	12
2	Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis 2017 ·Arthritis & Rheumatology ·Mark C. Genovese, Maria Greenwald, Christine E. Codding, (unknown), Alan Kivitz, Annie Wang, (unknown), Xuegong Wang, Jay Garg, Mario H. Cardiel	75
3	Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double‐Blind, Active Comparator– and Placebo‐Controlled Study 2017 ·Arthritis & Rheumatology ·Francisco J. Blanco, R Möricke, Eva Dokoupilová, Christine E. Codding, Jeffrey Neal, Mats Andersson, Susanne Rohrer, Hanno B. Richards	140
4	One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study 2014 ·The Journal of Rheumatology ·Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilová, Jacob Aelion, Sang‐Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio, Shephard Mpofu	83
5	Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study 2013 ·Annals of the Rheumatic Diseases ·Iain B. McInnes, Liz Thompson, Jon T. Giles, Joan M. Bathon, Jane E. Salmon, André Beaulieu, Christine E. Codding, Timothy H. Carlson, Christian Delles, Janet Lee, Naveed Sattar	253
6	Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study 2012 ·Annals of the Rheumatic Diseases ·Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilová, Mazurov Vi, Jacob Aelion, Sang‐Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Shephard Mpofu	227
7	Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial 2009 ·Arthritis & Rheumatism ·Clifton O. Bingham, R. John Looney, Atul Deodhar, Neal A. Halsey, Maria Greenwald, Christine E. Codding, Benjamin Trzaskoma, Flavius Martin, Sunil Agarwal, Ariella Kelman	324
8	Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee. 2006 ·PubMed ·Deborah A. Marshall, Marcie Strauss, Dan Pericak, (unknown), Christine E. Codding, George W. Torrance	18
9	Tubulointerstitial Nephritis Due to Vancomycin 1989 ·American Journal of Kidney Diseases ·Christine E. Codding, (unknown), Michael Allon, Jan Piťha, Mariano Rodríguez	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact